Rona, Therapeutics Rona Therapeutics Announces NMPA Approval of IND Application for RN1871, a Novel Angiotensinogen -Targeting siRNA Drug for Hypertension 07.08.2025 - 18:04:37 Rona Therapeutics China View original content:https://www.prnewswire.co.uk/news-releases/rona-therapeutics-announces-nmpa-approval-of-ind-application-for-rn1871-a-novel-angiotensinogen-agt-targeting-sirna-drug-for-hypertension-302432290.html